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FINAL SUMMARY REPORT
Contract Number: NAS 9-15194
Principal Investigator: Dr. H.N. Munro, Room 56-225, 14IT
Reporting Date: 17DT778
Title: Potential Use of Nutritional Factors to Optimize
Performance under Stress.
Period of Contract: Dec. 1, 1976-1;ov. 30, 1977.
Personnel:
1. Dr. H.N. Munro, Professor of Physiological Chemistry,
M.I.T. (loo effort from Dec. 1-Nov. 30).
2. Dr. Marilyn C. Crim: Research Associate, M.I.T.
(10% effort from Dec. 1-Sept. 30).
3. Dr. Frank Tomas: Visiting scientist, CSIRO, Adelaide,
Australia (25% effort, April 1 - Sept. 30)
4. Richard Reimer, undergraduate, M.I.T. (10% effort,
June 1-Sept. 1).
Objectives:
To examine the role of dietary protein and amino acids on
responses to stress, with a view to optimizing performance
under stress in flight.
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General Description;
The work proposed arises from a study some years ago in
which it was shown that the adrenal gland of the rat responds
to intake of protein and individual amino acids in the diet.
Specifically, the amino acids leucine and methionine were found
to stimulate output of corticosteroid hormones from the gland
for a period of several hours. Continuous administration of these
amino acids lead to changes in adrenal steroid content. It was
concluded that this change in adrenal function is probably
affected through ACTH secretion from the pituitary gland, which
in turn may be regulated by changes in hypothalamic secretion
of corticotropin releasing factor (CRF) resultinf, from the
administration of these amino acids. As part of the program,
it has been possible to extend this to the question of how much
the blood levels of corticosteroids need to rise in order to
cause adverse metabolic changes.
From these observations, it was surmized that the judicious
use of dietary protein, and specifically of certain amino acids,
may allow the response of the adrenal cortex under stress to be
controlled by appropriate dietary means.
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Summary of Report:
The report falls into two parts. First, there is a study
of the effects of amino acids on hypothalamo-pituitary capacity
to secrete ACTH, and the response of the adrenal gland in terms
of corticosterone level in the plasma. Second, the report
includes a study of the response of protein metabolism various
levels of corticosterone elevation in the plasma. lie regard this
second part as having considerable significance for space travel,
since our data indicate a threshold level of plasma eorticosteroids
above which there is increased catabolism of muscle protein;
Part One: Effect of Amino Acid Intake by Rats on Levels
of Corti.costerone-Releasing Factor in Hypothalamus,
ACTI1 in Pituitary, and Cortisol in Plasma.
Project 3.2 on p. 5 of-original description of .ask described
the objective of this section as follows: "The study will
provide ^hformation on whether excess leucine will influence
plasma corticosteroid levels through an action on hypothalamic
function". The following data were obtained.
1. A study has been made of hypothalamic, pituitary and
adrenal function in rats fed leucine or alanine up to 24 h
before killing.
2. Procedures for ACTH measurements in isolated rat
pituitary glands were developed. These were used for pituitaries
alone or exposed to fluid from hypothalami (perifusion).
3. Perifusions using pituitaries from rats fed different
diets tend to show that the basal rate that leucine pituitaries
secrete ACTH is greater than the basal secretion of the alanine
pituitaries. This is accompanied by sustained output of a
fragment of ACTH called "CLIP", which is known to stimulate
insulin output.
4. When hypothalamic e ,-,tracts were used to stimulate ACTH
secretion, there was increased secretion of ACTH when leucine
was pre-fed.
5. At 4.5 hours after feeding, the plasma corticosterone
levels from rats fed leucine showed a significant increase when
compared with alanine fed rats. At later tides measured there
was little or no difference. Feedback inhibition exerted over
ACTH secretions by the corticosterone concentration could explain
why there is no significant changes in ACTIi and CRF at 18 hours
after feeding.
6. It can be concluded that administered leucine increases
the concentration of ACTH by acting on the pituitary, the
hypothalamus or at some higher center at approximately 4 hours
after feeding. The increased basal secretion bf ACTH and the
higher values of ACTH content found in the pituitaries of leucine
•	 treated rats 18 hours after leucine could be remnants of the earlier
stimulation.
7. This work continues to open up the prospect of controlling
stress by dietary means, through changes in capacity to secrete
ACTH and corticosteroids.
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Part Two: Effect of Glucocorticoids on Myofibrillar
Protein Breakdown Measured by 14 -Plethylhi.stidine
Output.
NT-Methylhistidine (3-McHis) output was measured in the urine
of young male adrenalectomized (adx) rats injected with 0, 0.2,
0.5, 1, 5 or 10 mg corticosterone/100 g body wt daily for 7 days.
All rats were pair-fed with the untreated adx rats. Intact
control rats and adx rats on doses between 0 and 1 mg steroid
grew at similar rates, whereas growth immediately ceased on 5
and 10 mg doses. Output of 3-14eHis was unaffected by adrena-
lectomy or corticosterone at doses below 1 mg, but increased
slightly on 1 mg and about 2-fold on 5 and 10 mg doses. At the
two highest doses, the weight of the gastrocnemius muscle rela-
tive to final body weight was 250 less than in untreated adx
animals. The soleus and extensor digitorum longus were unaffected,
while liver wt. increased considerably. The changes in gastro-
cnemius and liver weights were not seen at lower doses. Treatment
with steroids did not maintain plasma corticosterone levels above
those of the intact controls until dosage reached 5 and 10 mg,
when the plasma concentration was 2-3 fold greater at 5 hr after
injection. These high doses also caused glycosuria and elevated
plasma insulin levels. It is concluded that corticosteroids do
not normally regulate myofibrillar protein breakdown rate, but
that excessive levels in the plasma, equivalent to severe stress,
can accelerate breakdown.
Conclusions and Recommended Actions
The above data emphasize that certain high plasma levels of
corticosteroids are associated with increased muscle protein
breakdown as a stress response. The role of certain amino acids
in the diet in the production of such levels of steroids indicates
dietary participation in the response to stress which could be
manipulated.
Courses of Action:
The current contract has run out. It is suggested that the
implications of steroid levels observed in astronauts in flight
should be considered in relation to our findings and dietary
contributions to such steroid levels evaluated.
Appendixes One and Two:
Detailed descriptions on the above work. See following pages.
rApprendix One: Effect of Amino Acid Intake by Rats on Levels
of Corticosterone-Releasing Factor in Hypothalamus,
	
4	 AC11 in Pituitary, and Cortisol in Plasma.
1. BA(IE C "iU110)
A. IiC TH
Cortixo •trophin (ACTH) is a 39 adno acid hornone with a
molecular weight of about 4500. It. is known to be synthcsizcd
and stored by the aderiohypophysi c. It is synthesizes: by the
placenta and high concentrations of' the hor.-*:one have been
found in the hypothalai::Lss and other Ci:S areas (II'z'_-e^;er et al
1917) . The structure for ACTH has been determined for several
speci_eu, and for the pig, sheep, beef and human -the molecules
are iocntical except for a variable re-ion of the chain
between amino acids 25 to 32 (figure 1) . Rer.:oval of the C -ter-
urinal amino acids (25-3c) resi.ilts in no lows, of biolo,;ical
activity, the active ror •tion of the raol.ecule bc3.r:^ the i:i 2-
terminal 1-24 region.
1. Fhyslol.o-ical actions.
ACTII is priMari.l.y synthesized and stored. in the adenohy .o-
physi;; . Its target oman is the adrenal cortex, which concen-
tra•te:, -the AC LIH. its main effects on the adrenal cortex, arc:
i.) It increases adrenal corticoid formation and content ,
ii.) It increases phosphate turnover and the hydrolyci s of
cholesterol_ esters.
iii.) It decreases the adrer<^.1 concontration of cholesterol.,
ascorbic acid and lipids. (Schulster, 197 4 ) .
It is thoul , ht that I.0 ii. acts via the second nesseriZer
al,19 ;) . "'he cAI.X i.nduco: a red ul.ator protein. -to be , nt!,vni-_cd
and tiim chi s, 1,ro tc:Tn trannrer:: cholcstorol. f.ron th-D Lipid
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pigure 1. Compari.00n of structure `i of cdrenocorticotrophino from
fogy cuifferent sPeci.ec.
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Pig; ACTII	 r",I »— Gly— :^lw—Glu—asp—Glu—Leu—^lw—Glu
Nil 
Sheep -c:C TII	 Ala—Gly—Glu— Asp—:asp—Glu— :° la—Ser—Cr^ L^
11H^
^2
Beef ACTH	 Asp—Gly—Glu—:.lam—Glu—:^ p—Ser—'1'—Glu
IdH2
IIu-nan ACTH	 A` p—G1_y—:?la—Glu-Lisp—Glu—Ser--Ala—Glu
From Schi1ster (1_974)
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droplets to the mitochondria (v,,here	 -the rate ].imi-ting steps for
steroidoC.onesis take place) . (Garren et al, 1971) .
In the rat., -the release of corticostcrone has nul::erous effects
includi n-increasing; gluconco cnesis, ^;.ly rr^;^r n^: d1^ posi-tion, -	 -
d.egradin; albumin and accelerating uptake of amino acids by the
liver (fiddle, 101711).
2. Synthesis-, storage, release and transport of ACTH.
Tho adenohypophysi_s synthesizes, stores and releases ACi11 in
response -to a dual control mechanism. It is under feedbac':
control by the concentration of corticoids in the blood. It is
also contrcIled by -the hypo tilalaa.Iic releasing factor (Cif^) . Tile
CRP responds by increasinc, output of ACTH as a function oa the
rats circadian rhythm (erith a naxiriuvi release occuring just
be fore 1'!aiiiri°,) , pain, pyrogens, hypo-l-celni p. and as a respons e
to increases in vasopressin concentration. (Gill,19 72).
The rat pituitary contains approximately 1;-00 ng ACTiI per
1C-0 um.-is body wei ght, (Scott et al, x-974) . I" is carried in
the plasma as free ACTii. In the rat, the 	 of endogenous
ACTH has been estimated as 1 minute (Snydor and Sayers, 19^3).
About 20i'0 of endogenous ACT:: is
(Schulster,1974) . !?or the rat r
-reported as around 23- 63 p,/ il.
climb to betr:een 250-2000 p^jml
3 . 1- 1.	
td .L
ea rt^r. ^, Icn-t o -_ 	^, l,i .
-calt en. up by -the kidney
estin- levels of ACTH are
Af-'er -tress these levels
(:1ees et x.1,1971)
L'ue -to the very loti-1 cor_centr5-C'L-i.on of ACTH in the ra pt:, the
measurement of ACS';' re q uires a very sensitive and precise aocay
.J 1
At this time there are 2 Uenerally accepted assays for the
measure:.iont of A(;TII. One is a bi.oa:,say and the other is a radio--
lramunoa asay .
The bioassay (Liot-ta and 31brieger,1975) ira':es use of isolated
adrenal cells from h rpophysectomized ani:eals (Sayer 's,197?) . L'y
using a silicic acid extraction of the Plasma this bioassay is
able to assay samples with concentrations of ACTII as low as
2 pg/r .1.
The RIA (Rees et al,1971) uses the chloramine T oxidation of
Greenwood and zunter (1963) to label -'Cho A(7, , T::. The antiserura was
raised against -the I1112--terminal 1 ­ 24 p02:• -i I.on of AC Tli . Samples
are extracted Yri_th glass, desorbed using acetone, the extract
is mixed with anti-serum and incubated. Sepogration of bound and
free fractions i s done with cllarcov.l. The assay is sensitive to
concentrations as low as 20 P- al. The RIB: used in these experi-
ments is based on Rees technique.
D.	 Theory-and ' P ractise .
The EIA is an example of a general type of technique called
a competitive binding assay. ":s -the name irnl)lies, there is
competition, between an unknovrn and some type of labeled com-
pound, for a limited number of binding si lues on some molecule.
Usually the competiti o -n is between an ur1_nown, or standard,
and a radio-labeled molecule whi c'n has -the same structure as the
unknown. The binding :molecule can be a cell membrane receptor,
3 tx•^.nn-port- protcin, or an cn ,1-y-mo but it i.S usi?ally an -r_tico
A fixed amount of radio-l...beled anticen is rai::ed with a
1 r..
sample con,16-ai.ning the unlabeled antigen. A limitin- ar-ourit of
antiserums is added to the mi;:ture. After an incubation Lille in
vihich th-e antigens c q uilibra to between the bound and free cts:.tes,
these fractions arc scpaxated and the radioactivity in the
fractions are counted. (See figure 2).
The concentration of the unrnovm can be c2.l.culated by com-
parison v.,ith the displacC'Ment of -the labeled antigen by a sot
of standards (.figure 3) . in this vmy one is able to evaluate
the eamples as a Function of the percent of count: bound to
the antiserum.
The technique, as first introduced by Gerson and Yalov: (1950)
for the mcast!re ment of plasma insulin levels, is now used -to
meas«re many pep-tide and non-pept i cue horm.oncs, drvgS, seru m
proteins and other biological saT^ples (`lalov', 1 973) . An RIA
has 4 specific requirements which arc:
1) An antigen, either synthetic or highly purified, -', Or stan-
(lards and radio labeling,.
2) -A antigen which should be of a high specific
activity. I ,;oct proteins are Labe]-ed using 125T OCiinc. The 125I
attaches to the tyro -Sine residues. The use of chlorar-ine 1T has
enabled rla.^y pen-L, 	 to be I.aUeled.
3) A specific antiserums. 'his 3- s usual.ly raised in rabb.it,,
goats or sheep. i,:ost peptide hori,mones are it:^?i:unogcni.c vfaem
ermIsified in Fremds ad luvant (^alovr 1	 ' peptid>^3	 hen the	 e
is too small to be ar.L` C cni.c, i-t can be re_.: e yed so by c2cl., r) .r
P igur_e	 standard curve.
(rRTsl:	 l,hl^la.)i p (S1'I:CI )'JC ANTT GER--AN-1'i.) ODY
AXNA CEN) AN'1'l ltOT)1') Co: Ti'),I??
I /)!
.	 (UN),APIRL1:U ANTIC 13%')
'
^CJ	
in knocan s .andar. d noluCions
or unknown samples
v
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Figure 2.	 Competing reactions that form the basis of t) 	 71-
(Yalow,	 1973)
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to a laracr protein.
A tgoo d inetho d of separation. !! fter incubation of all the
• component's of the a.-,say mixture, thcr must be a method to sepa-
rate the bound from the free fraction. There are several popu-
lar methods but they must be chosen to suit the needs of the
assay systein. The ideal technique should completely separate
i
the free from the bound fraction without cNUectinz the initial
bi.ndin- reaction. Cne"can use adsorption of free antiGen (to
glass, charcoal) , precipitation of the antibody-anti-en
complc;: (second antibody, salt solutions) or via adsorpjL-.-*,.on
of the antiserum (-co glass or dextran) . (:,atcli.ffe,197 1 ',) .
Since the RJA is able to measure conccr_•t-r. ations as Small
as 1.0 -121-1., i t is important, that the assay should be precise
(reproducible), and unbiased (no •t afsected by unspecific factors).
These unspecific factors (which must be carefully N %ratched for)
are pH, ionic envi_ror-ment, ant-i.coagulants, bacteriostatic agents,
temperature and hormonal cross reactivity. (Yalow,1973) .
I I . I Td'1' I;GTiL'C'1.`I OPi
In 1957, it Y!a^ establish ed that admini.utration of casein to
fas i in;, rats eau: ed an increase in incorporation of 32. and
(1'^G)--,;lycine into liver I;^;A (Clar,^ et al,1957) . It uras
subsequently shown that the mechan sip of response is sensitive
to the deletion of one essential an i.no acid from a complete
mixture of amino acids (L^unro and Clar'.:,1959) . This suggcsts
that the effect on liver R A metabolism depends on the nutritional
value of the pro Ce n. Hol:rever the feeding of zein (%-faich is
deficient in 2 essential amino acids, tryptophen and lycine)
led to the same s-tinulus on liver RI'A metabolism a:, casein
O"Aunro and 1.-ut:erj.i_,195c) . Since zein contains excessive ar..oun s
of leucine, it was decided to examine the effects of exeessivo
levels of indi viJual amino acids on liver IRNA metabolism.
Young adult rats were fed a protein free meal to which
individual amino acids had been added; 3 2F was injectcd one hour
later and the aninal.s were killed 18 hours thereafter. The amino
acids elycine, 1; ethionine and leucine increased 3 21 incorporation
greater than 65' when compare with control values. In explorinf,
the actions of these three amino acids -more extensively -I t  was
shovri that they induce a sib nifi_gj-4nt increase in total liver "I.
Dose re ponse curve-, demonstrated that the ac •fions of leucine
and methioni.ne on 3 21- upt-ake were lineer frog doses of 0.05 .
ur n-,ards, ^.hercas `1--cine required a ti-xesholc? ebsc. It rao also
:l:orm that a single large dose of leucine in -rats prodt,ce^ an
-:L6-
increment in liver protein (I•.unro and 1.1ukerji,19513) . After
giving cortisone, the amount of I;I:A and protein in the liver
incrcase5 considerably. Another Feature of adrenocorti.cal. activity
is depoFition of glycogen in the liver. After .feeding leucine,
methi onine or glycine it % •7as discovered there was an increase
in the airount of glycogen in -the liver. (Munro and 1.:ukerji,19C2) .
The same diet fed to adrenalectomized rats shovied no increase
In glycogen content. I-:.ca.surements were also made of -t?le effect
of adrenalecto-my on -the response of liver I,'iiA metabolism to
these amino acids. Adrenalectony prevented the action of methio•-
nine and leucine but only moderately diminished the effect of
glycine. This suggests that large doses of riethiorine and. leucine
cause an increase in adrenocorti cal hormones. This was to ted.
by rleasurin- the corticosterone content in the plasma and
adrenal glands of ra'cs being fed i nd.i vi.cuaJ. amino acids. oth
methionine and leucine caused. a signifi.Cant elevation of -the
plasma level and a tendency for the corticosterone content in
-the adrenal gland to be raised. (L:unro et a1,1963) .
More evidence for the effects of leucine on the adrenal_ cortex
comes from the studies by ;.un arian i%or%er.. (Goth et al,1955) .
They showed givi.nZ leucine to rats via stomach tube caused
depletion of the ascorbic acid content of the hc'renal. This
action does not occur in hypoph--secto;r_ized rats, suggesting that
theprimary site of action' is the pituit^ry
The evidence cv-gests that a single 1a.rz;e core of ccr'tain
1
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amino acids causer, increased secretion of cor-ticosterone,
presumably throuCh release of AG Il.Bitt-i.the work was carried no
further. The developemcnt of a sensitive assay for AC,*Tl; and the
ex3.stenu c of apparatuo to study the ros j on,se of or-ans -to a
flowing system (Edwardson and °cnnett, 9. 0,74) have made continv.,atien
of this wort. toossible.
The question of v.here the effect of these amino acids is
located can be answered using the above techniques. Extraction
of pituitaries from diet treated animals and the measurement of
i	 their ACTIi content can tell if the effect is located in the
pituitary. I'erifusi on of pi-tuitar:.es vinich are stimulated with
hypothalariic extracts from rats fed uifferent diets can tell if
the effect is localized in the hypothalarras.
By feedin- rats high concentrations of .leucine and a control
amino acid d i et, the location at ,-". ich lcucine acts can be
discovered. this is the purpose of the studies underta'-cn for
this thesis.
t
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A . Ani.mal.s anet Tissues.
r ;al.r. 'Spra{;ue-Da^,^ley rats (Charles, fiver Laboratories,
t
Wilmin^ton,i,:ass.) weighing between 150 -2_5 0 g. were used for
all experiments. They
 were housed individuall y and were exposedP	 ^	 J	 1
'to light bet ,,^ee 1 Z A1.1 8.:-:d 8 Pik daily. They were fed lab chow
and given viater ac? libitum for 3 -to 5 days prior to dietary
treatment. During this period rats were handled daily, 'Co
gentle and accusto=m them. to hu v.:1an presence.
Diet treatments began by fe.O.tj:j.rjg M-t.s 10 g. of control 6iet
i
I table 1.) at 4. rr on ciao►
 1 of the experiment. This feeding	 r
t	 period was considered a training period. in which the rats were
I taught to consur„e the pc rdercd food in a single meal.. A.t 4 1-11
on day 2 the rats were fed a 10, leucine or 10O' alanine diet
or placed back on the lab chow diet.
Animals were 1=illed by decapitation fron 11 Al.' to noon on
day 3, and the trunk blood was collected in tubes, (_for
corticosterone assays to be performed at -the Feter rent
Brigham Hospital, Roston, l:ass). Fituitar. ies and hypothalani
were removed (n, longer than 5 minutes after sacrifice).
Fituitaries for perifusion were halved and placed in a 30 
pool. of E.RrG buffer. Hypothalami that were to b6 extractcd for
rleasureMent of C'_ content were placed in 0.5 irl . of 0.1 N. 1-iC 1
to denature any proteases (the same treatment was given to
pituitaries when they were later e::trac-Led and assayed -for
F	
-ln
`fable 1. Con1;c:1:-i_^^ e::l^cri.-^en i;7 1 cict
Protein Free Diet
?nutrient
Glucose -
Corn -:,-torch
Corn oil and d, 1, atocophcrol
I.iinera]. r.:ix
Coe, liver oi l
Choline
plater soluble vi tan:ins in sucrose
g, rams, 9. 00 g .o f d?. et
11 6
40
6.7
5.3
1.30 .14.
0.3
Control uiet
(25 Protein, 75i' Frotei.n Free ctie t)
Fr. otei.n free diet	 7.5 a
C asein
10.0 {;.
Frotein free dAet
Starch- do,trose
Loucine
r
Frotein free diet
Starch- dextrose
A lam re
I•e^^.c i ne Di et-10'
7.5 c•
1.5 G.
i . 0
10.0
7 . 5 g•
1. 5 c.
L!-0 g .
1"N .0 g.
lab chow- Cha'r]_cs 'fiver. fi at-I:}ouse-Hamster Eaintenancc Formila
(Charles :)1ivev i.ao;	 I,:ass.)
ORIGINAL PAGE IS
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Iiypothalami were extracted in the 0.5 ml. of cold IIC 1 using
a Duch ;"22 homoGeni zcr . The acid extract was poured into a
rla^-t.ic ,tube and the horr:o`eniv.cr v.-as v.,ashed. viith 0.5 T.A.. of
0.1 i; . ]IC 1 and the wash was mixed ['iith the extract. i:omogenates
were spun at 12.000 G . for 10 :!,i.nutcs (at 40C .) . The s caper. na'tents
were removed and brought up to 1 ml. volume, (this concetration
is referred to as 1 hypotiialami.c equi.valcnt
	 and wa.
assayed for G,.^.F ^,,ia perifusion. In the case of frozen pi.tuitaries,
on the assay date, they received the same treatment.
Peri fusior. s
Different experiments were perfor:Med by feeding rats lcucir. ,-- ,
a.lanine or regular lab chore. These rats were then sacrificed an
pituitary halves (.f. rcm the same or difi'erent dietary 'L-.r.ca'tme:rtU)
were peri fused in the two chambers of the apparatus. The
pituitaries were stii:iulated with. different II- and fractions
were collected, Nraitin^ approXin,atel-y 1 0 minutes between
different HE viere added) . In this vmy the (:-:F coik).d '-.e
(as a function of incrcase in ACTH output by the pituitary) , and
each pituitary could act as its o%-.-P. control.
I
---mow-
C . :;cat•entr
h-ACT1f : u^mthetic C•v^r j^iatrophin (a* IL'/rig.) provided by the
12 'I-ACTH: iod.inatE: 	 AC	 prepared as described in the text
ACTH Antiscrw-.! Ant: •_ura to ACTT prepared in rabbits aggai-nst
Porcine ACS;., provided by 11M. D;7.
RIA Buffer: 0.02. 5 I:I. sodium r_hophatc, 0.25, BSA pH 7.6
'ihis buffer is used for all standard dilutions,
125-I-ACTh cl.i.lutlons, antiserum dilutions and for
final preparation of :ihicl: .Dashed Iiorit.
ESA:	 Bovine serum albumin, ICI• Pharmaceuticals Inc.
Cleveland, Ohio.
T^ormal horse serun;: Grand Island Bi.oloGi cal Co. ((05)
Grand Island., ;y . 1'..
n
I1or- it A: Acti-vated charcoal prepared as fol lov ' s :
20 U,. charcoal- to 200 ml. with 0.1 'N lic' l
Stir 20 minutes.
Transfer to a cylinder and let stand 20 minutes
Aspirate s uperna •t•en t .
;Nash with wat-er 3 ti::es by aduin- 250 r:ll de-ionized
water, ::iix by inversion, let stand 10 r.^.inutes
and a s- -irate siircri-:a.tent
Wash vd uh O.C25 i•:. IT 4 buffer (p;: 7.6) 2 times. l^:ix
by i n\, 6rsion, let stand 2.0 Minutes and asriratc
suporna.tent .
Check pii (7 . 111 -7 .6) . Store at 40C .
Thick Washed ;Iorit: .15 rnl' ;:i»^i ^ r
2 ml. 0.25
	
buffer (rii 7.6)
15 T-.11.I^orr^al horse servin
3 ml . D' 0 -ioni zcd %,ater
1tr,BG:	 K-• ebs R i.nrer suffer with glucose, :'.34, and C2
110 ru" soc?itim chloride, 25 TO-` sodiut:i bi.carbo—nate,
4.7 r^?: ro tassiu!,.i rhosrhate, 2..52 rnl.: calcivr:i c:ilori_de,
gar for 5 :ai12?ute:-. `.'!i'til 95j^ C 2/5 t: C 2 ( v/v) 0.2'
glucose, 0.25 1'SA .
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125.D. F'rnpara.V on o1'	 S-ACMI
Three types,,pes of 1251-AGT11 wore used.. The first was a gift from
Dr.. Framo Sanchez, from `^ufts University Schoo) of Medicine,
];oston, I;ass.. The second was iodinated in our lab and the third
was from Amer shari/S earl e ACTH' Irrrunoassay Kit I1-1.66 (Arlington
Heights, illi.nois.).
1. Iodina cion reaction.
125I-AC^liI of high spedfic activity was prepared by ioc'.inating
synthetic h-AC^)I by first oxidizing it with chloramine T,
neutralizing; the mix, extracting with glass and then pur. ifying
it on a Sephadex G-25 column.
To a vial containing a basic solution Of 0.5 i:1c . Na1 X51
NEN' X03 L Dos-ton, I1ass .) the follocring viere added:
10 u1. of synthetic h-IBC TI-11 (2 ur)
50 ul. of 0.5 ii I-Oh, buffor (ril 7.6)
25 u1. of chloramine T (1 r:.,77ml. r?ixed inmedia^tley prior to
use and protected fro;^ direct light) .
The contents o-,° -the vial are Nixed from 15-20 seconds. I':o longer
-than 20 seconds after the addition of the chloramine T add:
25 u.l . of sodiuri metabislflte ( 2 mg ./ml . , mixed im-mediatley
prior -to use)
The chloramine T is a strong oxi dizino anent which ray signifi-
gantly damage the AG'iH, sodium metabisulfite i.s added to neutrali ze
the remainder. Then add:
50 ul. of ' A (5
	
and mix.
^'he total mixture is added. -Io 10 ^;. qu:o F;lass (G 3?., 1`hila-
delphia Quartz Ga., i h_1c.. , Fenn) , in a pla ,tic -tube and
MOMW V
vortexed .
2. i • uri.fication of 1?5T-ACTH.
One ml.. of de-ionized 11 20 is added to the quso glass mixture
4	 and the ,m.ixture is ccntrifu,[^ed at 1000 G . for 5 minutes (at LI• 0C •) .
The supernatent i;I docan •tcd and. •thc '1as:, is washed by add • ng
1 rql. or de-ionized 112  vortexing and centrifuging at 1000 G .
for 5 minutes. `Phis v,,ash is repeated 2 times. The 1X5 1-ACT &
0	 (now adsorbed to the glass) is desor •bed using 5 T.A. of a 14•C'
acetone/1;o acetic acid rli': (v/v) . The tube is vortexed and then
centri uf-ed at 1000 G. for 10 ninutes. The supernatent is
aliquo •ted into 0.8 i71. fractions vAni_ch are frozen at -20 oC .
Frior to use, the ali q uot is passed through a 50x2 cm.
f
	 Sephadex G 25 ( coarse) column, equilibrated with 0.1 1;- acciic
acid and 1.25 r1g./rnl. LSA 4I,;' 3.C) . The floc: rate of the column
is 1 nil. per 10 minutes. Cne rol. fractions are collected in
plastic test tubes. The tubes are counted for 6 seconds to
determine the radioactivity per tube. The counts are plotted Land
the 1251 will be found at the second pea': of radioactivity.
(Franco Ca.nciiez, personal communication) .
lodinati on check.
The ::uccess...of the atte::.iptcd iodination is chcc%ed by rixinL
50 1l.1 . of appropriately diluted 1251-ACT;I (7000 cps i/50 ul . )
witiz an excess of antiserurrn (50 ul. of antiser-Lim dieted 1:2,50).,
and 100. ul. of I;TA buffer. The ear^files are incubated 2",- 36 	flour:.:,
cou:% ►t^.d, ... n;.rr.^ed (i:,in^ 1• ^c. :.a.^^ec^ ,or--^ 	 an L tae cot t
adsorbed to the c':urcoal are counted.. wince there is an excess
of an'ti^crum alr.,ost all of the counts should be bound to it (if
the iodination is successful) .
E. FrQMara.tion of the antiserun.
Three types of antiserum were used throughout the course
of these experiments. The first antiserum was a gift from Dr.
J. A. Edwardson, of the Depart=ment of Biochemistry, Imperial
College or Science and Technolo y, London, England. He received
it from the NIALIDD and the National Pituitary Agency of the
University of Maryland. It was raised against thei 2 terminal
portion ( 1 -24) of porcine ACTIi and. does not give sitnifigant
cross reaction ''!i th	 The second antiserum was a gift to
our lab froth the MAI•IDD. The third type of antiserum VM0 from
the Amershan/Searle ACTH inmunoassay hit.
F. Anti. serur. t itrs.tion.
Antisert?m1 was serially diluted 1 x 10 3 , 2 x 103, 4 x 10 ,
8 x 10 3 , 1 6 x 10 3 , 32 x 10 3 and 64 x 10 3 using RIA buffer. To
each tube was added 50 ul. of serially Oiluted antiserum, 50 ul.
of the appropiatl.ey diluted 1251-AC` ]1 (such that 50. ul. con-tainsd
7000 cpm) , and 100 u1. of RIA buffer, They were incubated from
24-36 hours. After incubation, the -tubes were counted and then
i;iixed v!i'th 200 ul. of lhich bashed horit, certrifu-ed and the
superna.tents removed. The cha:
rpercentaze of total 2,I-A(;T;i
calculated. The desired titer
vL.-i?e a new batch o; 1251-::(.: .i
rcoal residue
bound to the
i s 50,0 o f t]
W<1 1 IMed, a'
was counted and the
antiserum was
e counts bound. each
an'tJ.^ert?	 i;} "I:?.'c';5.!J^
1
^?,^
	 Now-
wa.s performed.
G. As av roc(-, 0ure .
To each assay tube was added in the following order, 50 ul.
of properly diluted 1251-ACTH (7000 cpm), 100 ul. of standard,
blank or unknown and 50 ul. of properly diluted antiserum (N•rhich
binds 50^ o f 1X51 -AGi'Ii) . The tribes were vortexed and then stored
at 40c. for 24-36 hours. After this incubation time tubes were
counted. Then 200 ul. of Thick t'Iashed Norit was added to each
tube. `The tubes were vortexed and then imrlediatley centrifuged
(no more than 5 minutes from add.in3 the charcoal) at 1000 G. for
5 minutes (at 400.) . The charcoal adsorbs unbound ACTH, and by
counting the 1251-A(:TII adsorbed to the charcoal, the counts
bound to tae antiserum can be calculated. The standard curve
consists of serial dilution of synthetic h-AC' TH (diluted ;Ii.th
RIA buffer), using concentrations of 100,50, 20,10,5,2,1,0.5 n^./rll..
Along with the standard curve a tube containirz 50 ul. of diluted
1251-ACTH z,. d 150 ul. of i;IA buffer are added. This tube is
treated like a
a sufficiently
a-ny counts not
Therefore this
11 other assay tubes. Since the charcoal. is in
high concentration to adsorb all of the 1 2 5j. 	 Ti:
adso,bin to the charcoal represents damaired AC^'H.
tube gives an index of the 125I-ACTI1 not
specifically bound to the antiserum, and it is labeled !%- S_D . All_
tubes were run in triplicate. The starida.rd curves are plotted as
the percent of counts bound to the a.ntisc-rum. Therefore ccuntin-
the counts adsorbed to the charcoal ("rea 1251-AC"11i) and
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and subtracting this,  from the number of counts originally i.n -the
tube gives the number of counts bound to the antiserum. Dividing
this by 'the rnimbcr of counts originally in the tubes gives you
the pc(R.ent of counts bound to the antiserum.
}i. Pe r. ifusi.on arrara.•tus.
The apparatus used for perifusion is shown in figure 4. '
According, to experimental condition::, 2 or 3 rat hemi-pituitaries
were placed in the millipore holder which served as the perifusion
c').amber. Care was taken to make sure that no air bubbles were in
-the chamber or any ilow lines. The pituitaries were perifus(,cl
usin)- KREG buffer. A13. perifusions and buffers •;ere at 370c
The flow rate ti:as adjusted so 0.2 ml of buffer flov.cd per minute.
Test hypothalamic extracts were kept on ice, warmed 'to 37 oC . and
-then added via the three way valve at the top of the chamber.
using the 2 chambered apparatus, 2 pituitaries frori animals
receiving different dietary treatments were able to be perifused
at the same time, permitting testing and comparison of caiiple,
under equivalent conditions. All perifusion' samples were :•^ ..
culler ted as i. ml. fractions (5 minutes:) and were immed.iatley
frozen. Sariples were stored at -2.0 0C . anti 1 analysis was
performed.
1. Statistics.
Statistical signifigance between group: :ias determined by the
Student I s t-test .
T '	 _
-27-
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n
	
F"I.C'urc ^1,.. ,y '0 n ,^^~^.:^u^^on anr,^.nat;ua
	 (; d.r:ard con and Fcnnot't,1971t)
Pituitary
f :	 Milliparc filter
holder
—Tc,t samp?c .
Pcrifusion medium— — .- 	 } I=a--\Mater 37 °C
Pump
°
Fraction collector
	 °	 -
II
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TV. RESULTS AND i)ISC SSIO' ^
A. Antiserun titration.
Due to the 60 day half life of 1251, antiserum titrations were
r
run on each new batch of 251-ACTII. At the beginning; of tine
course of experiments the Edwardson antiserums was used. After
0	 receipt of the I.IAI.,DD antiserum, it was titrated. The NIALIDD
advises a 1:120,000 dilution for 50;0 b inding; of ACTiI. No si gnifi-
ga.nt binding was visible at antiserum concentrations as hi gh as
1:1000. Therefore -the E(Iviardsc,n antiserum was used for all of
these experiments (e;;ce.,t when the Amersharn/Searle kit was
used). The Edwardson antiserun was usually diluted between 1:2000
and 1:8000.  At this concentration it gave 45-50;"P binding, of the
total counts.
E . I odinat i on.
Iodination was attempted once during the course of these
experiments and purification was attempted tv rice. Dotii times
the G 25 elutte did not give the counting pattern desired (two
distinct peaks) . The only pea'c %^,as eluted about 120 ml. after
-the sample was placed on the column. Samples of this pea', were
diluted to give approximately 7000 cpr,1/50 ul.. This sample was
assayed with an excess of antiserum (1: 250 dilution) . The anti-
serum (v• hich was known -to bind ACTrI) dial not bind any courts.
The 1':S° was equal to 50" of the total counts. :Then antiserum
was added to tiic sample, the percentage of counts adsorbed. to
the cha-coal	 ch shoulO have been signifi.Lantly loi ,.cr) , did
not change. Therefore no !!CM;: was labeled.
Iodination- damage can have many causes. 1.1anipulations of s,.-all
quantities of a pure protein sample can reveal. instabilities that
are not seen v.►ilen the protein is in a cruder. form (i•rhen it is
protected by contaminants or carrier proteins). she incorpora-
r
'	 ti.on of 25I into the tyrosine residues can result in a. loss
I	 S
of affinity between the A~TH and the antiserum. E.,.posure to
strong; oxidizing agents li'•:e chloramine T, may result in s i,x;ni-
figant dar^aoe -to the antigen. (Hunter,1974) . But since AC1TII is
iodinated routinely in labs using; the same procedure, I feel
I
	
these possible causes do not explain the unsuccessful iodination.
I thin]: it is signifigant that the NIAL;DD sup-plied
  bothi	
antiserum (%,thi ch fe.il ed to bind ACTII) and the h-ACTH (i-Kiich v.as
i not succoos 1"u11' iodinated.) --:o-'L-.h were supplied in lynholized
glass vials, and ,:ere stored at room temperature for 2 raonths
prior to reconstitution and freezing. I feel that there is a
chance that -t-his storage right have led to dcE;radat'- on, which
v.ould explr_i n thy both the ACT}I iodination and the antiserum
titration failed.
0 . A ssatrs .
Initially the assay tubes had a large variation in radioactive
counts ( sometimes ran ing fror:l 50-200;' o f the mean) . .1ith
increasing experience and standardization of -becniqucs, this
variation was decreased. But as the manual techni q ues improved,
the T.anit, in the assay became arrarent. The early standard curve,
s?iov,ec] a lack of rcrF:atabiliL. . The cause of this inn re i-s on
was investigated without ever really curing the Problem. Times
	 ^ 1'
of incubation %-.,ere varied from 12 to 60 hours but the results
did not 'differ from the 24 -36 hour incubation. The variability
was found to be independent of order of addition of the reactants.
Accordin g 'to Ratcliffe (1974. ) charcoal in 'too high a concen-
trati.on can strip 'the antiserum of the bound anti-en. It was
discovered that the sane binding could be achieved with SO;o
of the charcoal, so this concentration was used.
The A;;icrshara/S earl e PIA kit was used for the most recent
experiments. Unli!. e the ea::^lier assays, the '.tit requires an
adsorption of the sample to poidercd glass and desorption with
acetone. All duplicates . ,.,ere repeatable and the assay gave
consistent results.
D. Studie s o n ACTH content and secretio n. b-% • rat ri tu ita.r. ,► `land.s.
14hen animals were first handled they were quite nervous a
res-,00nse typified by their squirming and "barking` . Since
stress increases the release of ACT}:, it was impor'tan't to
have the anirials familiar with their handlers. ry the -third
day of handli	 the rats were calmer and showed none of these
nervous responses. Cn the first day of dietary treatr.7ents
( control diets) the animals generally consumed all of their
food. On the second day of dietary treatments,, the group of
animals was divided. so that at least 2 anin.als ercre receiving
-ti- course study on the consumption of a 10;0
alanine versus a 10' leucine diet by the rats vas per.=ornec,
the same diet. A
44
(ii,sure ^)^. At IP hours after being fed, there was more lcucine
diet left in -the bowls than alanine. By B hours -this difference
existed but was less marked. By 24 hours, the 2 diets had been
equally consumed.
1. Peri. fu lion exr. er. iments .
All rat pituitaries were placed on the peri-fusi.on apparatus
by 1 hour after sacrifice. Ferifusion samples were collected
30 minutes after pituitaries were placed on the apparatus. The
results from 2 typical perifusions are shown in fi--ures G and 7.
In figure 6, line A hold 2 alanine pituitary halves, and line
E held 2 leucine pituitary halves . It can be seen -that 'l-ie
lcucine pituitaries responded Duch more readily to -the hypo-
thalamic extracts than the alanine nituitaries. The lcucine
pituitaries respond equally;;ell to the treatments, except for
the first chow hypothalamic extract, which seems not to have
stimulated an increased ACTH release at all. In lire A, -the
alanine pituitaries seem-not to respond to the choir hypothalamic
extract either. The pituitaries seemed to respond. to -the 1•eucine
and alanine hypothalamic extracts equally. In this experiment
the leucine pituitaries secretctta higher basal level of AC 11.
There appears to be a smaller CU, content in -the chovr hypo-
t_ialami vr,len compared to the lcucine and alanine hypothala-mi . .
In figure 7, both chambers A and L contain 3 lcucine
pitui tarn '_aloes . In chamber. A the chow anO leucine hypo", ala- m 2 c
extracts Ci.v e the biggest increase in ACTH release, A-Ah erea.s the
1^ j lure I 	 FOOD I INTAKES OF RATS ON 10 GM. MEAL CONTAINING
1 G14, LEUCI14E OR 1 GM ALANINE	 .
(Zero Time = 4 p.m.)
-	
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alanine hypothalamic extract gives only a small increase above
the baseline. The final alanine: stimulation N% ,as too small to
give a value. In chamber y the chow, leucine and alanine hypo-
,	 thalamic extracts give equivalent increases in ACT11 release.
The small increase in release caused by the final leucine
hypothalamic extract, parallels the small alanine stimulation
in chamber A. This may be clue to the exhaustion of the ACTLH
supply in the leucine pitui.tarl es at the end of the perifusion.
At this time the perifusions have yielded mixed results. In
It	 some experiments leucine hypothalamic extract seernis -to stimulate
more ACTH release than alanine hypothalamic extract (like figure
7, line A). In other experiments, the response appears to be
the same, (as in figure 0. Results at this tide support no
general hyothesis, but the trend seems to shoe; that leucine
pituitaries see-in to have a higher basal level of secretion .%hen
compared with alanine pituitaries.
2. Pituitary content of ACTH.
Pituitary extracts from both alanine and leucine -treated
rats are sho^,,rn in table 2. Values seem to vary between assays
but in the earlier assays, there is a hi. "her concentration of
ACTri in the leucine pituitaries when compared with the concen-
tration in the alanine pituitaries. = (^3ut this difference fails
to be siSnifi`ant at the 45 ;^
 
confidence level) . In the cost
recent assays ( done with the Ani ersham/Searle %i t) the values
seem to be very much ?.o: ,:er for the Ac;'_''.: content of the
pituitaries. These pltui.tari cs were frozen over 2 rnontho
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T.ab1c 2. Pituitan" ACTII coneen-trati.on / 1.00 Cxam bod y
 v:ci,
Di.ctnry lig. pituitzry ACTII / Averal-c n^. nitui.t^.ry
trca t,lcnt 100	 body	 .-:eit ht ACTII / 1.00 . body wt
1520
11.50
8 07
Alaninc 1010 1060 320
550
1360
10,110
830
1310
1.650
1000
Leucinc 1290 1520 t 500
2370
2090
1340
1750
Alanin0 220 290 1 9U
350
Leucinc N 21,0 260 ± i30	 j
280
measured with Amcrsham/S earl e RIA kit.
Tab1 c 3. Literature w0mc of pituit ar-►
 I!CTIi cone. / -100	 body wt.
Ids;. pituitary ACTII /
	 7tvern e ng. pituitary
Rer crone e	 1.00	 bocl.y %•:ei.rht
	 ACTH Y 100 	 bod.^ vit.
Scott (J-971)	 435
Scott (1974)	 310	 415 J: 1.00
iToriart$1 (1975)	 500	
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before assay (lon ger than any other pituitaries) . 1.1aybe the
lovier concentration of ACTT: can be attributed to some loss in
lb
imp.Quno-cni city due to freezing and thawing.
In table 3 there Is a comparison of values of ACTH content
of pituitaries found by other investivators. The values round
% %p ith -this labs RIA are 2-3 times Greater tha-r. those " found in the
literature. The values found usinG the RIA kit are lower than
those found in -the literature but they seen to be in closer
agreement. The differences found between our assays values and
the literature values might have many explanations.First- we are
workin,- with dif:cerent strains of rats, second the experimental
conditions differ and third our standards r:,ay be loner than the
value we assign them, thererore inflating the ACTII concetration
in our unknovms .
3. Corti.costerone levels.
In table 4, recent data on corticosterone _levels of rat
plasina are shol•,n. I t is apparent that the only
 time that there
:i_s a signi.figant increase in corticosterone levels is 4. 5
hours after the rats have been fed leucine. This result has
important consequences for the rest of the experiment. Since
the corticosterone level of the rut is controlled by the level
of AC HL, -Alien there is a chance in corticosterone it most
lilKely reflects a change in ACTE1 secretion (which in turn can
reflect a change In C:: sec.re tior) . Since -tile only t?.r:^e that
corticosterone levels are increased is 4.5 hour;; ai•ter it is
	 i
`l'^':b1C	 Pl ri Erna Corticostcr.one.
---	 ---
Levels:
--- (at time after meal)
4-.5	 hr. 8 hr. 17 hr. 24' hr.
L1,UCINP:	 :	 1. ' 63 7. 50 13. 6 18.	 3
7. 48 8. 6 14. 18 191.	 2
3. 55 9. 12 15. 1 1913.22
4:' 55 10, 33 16. 3 20A.32
5.. 48 3.1. 28 17. 47
G. 55 12. 30
Mean 54 27 15.. 15
71I^111JIi^r	 2013...18 26. 10 32. 11 37.	 23
21. 7 27. 28 33. 29 38.	 43
22. 18 28. 32 34. 10 39.	 9
23. 39 29. 21 35. 10 40.	 6
24. 23 30. 36 36 ?
25. 51 31. 25
Mearl^ 26- .25 15 20
r	 .
L^	 r
a
clear that this is the time to measure :for changes in C F and
ACTH. Since aninals were norviall y sacrificed 1# or more hour;
aftcr fcedi.nF;, and at this time there is no increase in
corticosterore levels, increases in CYT and ACTH vhould not
be expected.
6
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5. Further studies of hypothalamic and pituitary responses
to leucine.
With the cooperation of Dr. Edwardson, Dept. of
Physiology, St. George's Hospital Medical School, London,
hypothalami and pituitary glands from rats fed leucine or
alanine were studied, using two antisera for ACTH, one of
which recognizes the N-terminal portion of the peptide, the
other the C-terminal portion. The latter can be removed
from ACTH without loss of its potency for adrenocortical
stimulation. There is some published evidence that the
excised C-terminal portion (so-called CLIP) can cause release
of insulin.
Rats were fed 0.25 gm leucine or 0.25 gm. alanine in 10
gm. of the non-protein diet and 24 hr. later their pituitaries
were perifused. Fig. 8 shows that the leucine-fed animals
released more ACTH into the perifusion medium over the first
three 10 min. periods of perifusion,whereas the alanine-fed
group remained at a low basal level. Second, a large amount
of the C-terminal (CLIP) peptide was released from the
pituitaries of those fed leucine, and this persisted throughout
pe rifusion, but alanine feeding did not evoke this response.
This implies that a reserve of ACTH and even more of CLIP
exists in the pituitaries of leucine-fed rats,.
This could be due to residual action of CRF in the pitui-
taries, and therefore a final experiment was performed to test
for the C12F content of the hypothalamic of leucine-fed rats
were fed 0.25 gm. leucine or alanine or casein in 10 gm. of
non-protein diet. Twenty-four hours later, their hypothalami
•	Ak
- ---------
p. J--
I^0 _
	
-^N►1, p	
_	
_ _
z	a,
ro	n	
C
I	^ 4
L-il 
^.
v,	
- -L--^
771
 i.
20.8+4.3(Ala)
24.2+6. 1 (Casei
II	 33.5+4.1(Ala)
34.6+6.8(Casei
* Controls fed either alanine o
There were 5 studies in each gro
I
TABLE 5
Release of ACTH when Hypothalami are Incubated with the
Pituitaries of rats Fed on Stock Diets.
ACTH release ng. rul. raedium)
Expt. Number	 Control animals3—Lein c ne-fed
compared with alanine fed rats.
was little or no difference. Fe,
f^.
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were removed and incubated with the pituitaries of rats fed
on a stock diet. Table 5 shows two such experiments which
agree in showing a greater release of ACTH from the
pituitaries incubated in the presence of hypothalami from
rats that received leucine. I•]ote that casein feeding does
not have this effect.
V. SUMMARY AND CONCLUSION	 (^^
1. A study has been made of hypothalamic, pituitary
and adrenal function in rats fed leucine or alanine up to
24 h before killing.
2. Procedures for ACTH measurements in isolated rat
pituitary glands were developed. 'These were used for
pituitaries alone or exposed to fluid from hypothalami
(perifusion).
3. Perifusions using pituitaries from rats fed different
diets tend to show that the basal rate that leucine pituitaries
secrete ACTH is greater than the basal secretion of the alanine
pituitaries. This is accompanied by subtained output of a
fragment of ACTH called "CLIP", which is known to stimulate
insulin output.
4. When hypothalamic extracts were used to stimulate ACTH
secretion, there was increased secretion of ACTH when leucine
was pre-fed.
5. At 4.5 hours after feeding, the plasma corticosterone
levels from rats fed leucine showed a significant increase when
-41-
ACTH secretions by the corticosterone concentration could
explain why there is no significant changes in ACTH and CRF
at 18 hours after feeding.
6. it can be concluded that administered leucine increases
the concentration of ACTH by acting on the pituitary, the
hypothalamus or at some higher center at approximately 4 hours
after feeding. The increased basal secretion of ACTH and the
higher values of ACTH content found in tiie pituitaries of
rats leucine treated 18 hours after leucine could be remnants
of the earlier stimulation.
7. This work continues to
controlling stress by dietary r7
capacity to secrete ACTH and co
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l	 Appendix Two:	 Effect of Glucocorticoid Administration on the
In Vivo Rate of tluscle Protein Breakdown in
Rats, as Measured by Urinary Excretion of N T-
Methylhistidine
SUMMARY
The role of glucocorticoids in regulating the rate of
muscle protein breakdown was evaluated by measuring excretion
of N T- methylhistidine (3-Mehis) during administration of
i	 various levels of corticosterone to adrenalectomized (ADX)
rats. Groups of rats received daily subcutaneous injections
of 0, 0.2, 0.5, 1.0, 5.0 or 10.0 mg corticosterone/100 g
body weight/day for 7 days, followed by 3 days without hormone
I	 treatment, after which they were killed.
	 A group with intact
j	 adrenal glands served as an additional control. All animals
were pair-fed to the untreated ADX group. No significant
differences were noted in growth rate or 3-Mehis excretion
between the intact, ADX control, 0.2, 0.5 and 1.0 mg corticosterone
groups, whereas growth ceased and 3-Mehis excretion rose
markedly in the groups receiving 5 and 10 mg corticosterone.
Following corticosterone doses up to 1 mg, the weights at
death of the gastrocnemius, soleus and extensor digitorum
longus muscles per 100 g final body weight were no less than
those of the intact or ADX controls, and the weight of the
liver was not affected. However, following treatment with
5 or 10 mg corticosterone daily, the.weight of the gastrocnemius
muscle per 100 g final body weight was about 25% less than
that of the ADX controls; in contrast, the weights of the
other two muscles examined, relative to final body weight,
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► 	 did not differ from the controls. The livers of rats receiving
5 and 10 mg corticosterone weighed considerably more, both
in absolute amounts and relative to final body weight, than
those of controls. Plasma corticosterone levels, measured
on the final day of injection and again at the time of
killing, were reduced to near zero by adrenalectomy and were
little raised by doses of 0.2 and 0.5 mg daily, but were
increased to within the normal range by the 1 mg dose. At
5 and 10 mg doses, plasma corticosterone levels were sustained
at 2-3 times those of intact rat-, and thus in the range
reported for rats exposed to severe stress. Rats given
5 and 10 mg doses of corticosterone had glycosuria, and showed
considerably elevated levels of insulin in the plasma.
It is concluded that plasma levels of glucocorticoids within
the normal range do not regulate the rate of muscle protein
breakdown, whereas excessive plasma levels of corticosteroids,
equivalent to those seen in severe stress, can accelerate
muscle protein breakdown.
6The net catabolic effects of glucocorticoid hormones
from endogenous or exogenous sources on skeletal muscle are
widely recognized and well documented (1). Net loss of
muscle protein occurs whenever breakdown rate exceeds synthesis
rate. A depression in muscle protein synthesis rate following
glucocorticoid administration has been established (1,2,3),
but a specific increase in the breakdown rate of muscle
proteins has not yet been unequivocally demonstrated, although it
has been assumed to occur on the basis of increased proteolytic
activity in the muscles of corticosteroid-treated animals (4,5).
An increase in the in vitro breakdown rate of muscle
protein following treatment of rats with high doses of
glucocorticoids has been reported (6,7). More recently,
however, Shoji and Pennington (8), using similar in vitro
techniques, could not detect a change, a result which agrees
with in vivo measurements by Millward et al. (9) of muscle
protein breakdown in corticosteroid-treated animals. These various
studies are difficult to interpret since they involve different
muscles and differing types and levels of administered
glucocorticoid. In addition, in some of these studies, the
problem of reutilization of the labeled amino acid introduces
methodological complications which cannot be readily minimized.
We have used the urinary excretion of NT-methylhistidine
(3-methylhistidine; 3-Mehis), an amino acid present in
myofibrillar protein, as an in vivo index of muscle protein
breakdown. We have previously shown that this amino acid is
released upod breakdown of the myof.ibrillar proteins myosin
and actin, and excreted quantitatively (10-13). This approach
thus provides an integrated assessment of protein breakdown
rates in the total skeletal musculature and is an elegant
means of measuring changes in the rate of in vivo protein
breakdown in muscle Eee_r se under the influence of various
treatments. Here, we report the effects of corticosterone
administration to rats on the rate of muscle protein breakdown,
as determined by urinary 3-Mehis excretion; the results are
correlated with plasma corticosterone levels. It is concluded
that glucocorticoids do not influence the rate of muscle
protein breakdown until plasma levels of the hormone rise to
levels observed in states of severe stress.
EXPERIMENTAL PROCEDURE
Animals and Treatments: Adrenalectomized (ADX) and intact
male Sprague-Dawley rats, about 120 g body weight (Charles
River Breeding Laboratories, Wilmington, MA) were housed
in individual metabolic cages. For one week after surgery,
they were fed ad libitum a purified diet containing 18%
lactalbLunin (11) , and the ADX rats were given 1% sodium
chloride to drink. The ADX rats were then randomly assigned
to 6 treatment groups of 5 rats each. Treatments consisted
of a daily subcutaneous injection of corticosterone (purchased
from Calbiochem) for a 7-day period; each group received one
of the following doses: 0.0, 0.2, 0.5, 1.0, 5.0 or 10.0 mg
corticosterone/100 g body weight/day. A group of intact rats
served as an additional control group. The steroid was
injected in 0.5 ml vehicle, consisting of NaCl (0.8 06) ,
polysorbate 80 (0.4 90'), sodium carboxymethylcellulose (0.59,;)
and benzyl alcohol (0.9$), administered between 1100 and 1200
hrs each day, after the rats had been weighed. Both intact
and A DX control groups received injections of the vehicle
only. Intact controls and hormone-treated rats were pair-fed
to the ADX control group; the daily ration was offered after
completion of other experimental procedures, at about 1200 hrs.
Complete 24-hr urine collections were obtained from each
rat, beginning 3 days before and ending 3 days after the
7-day hormone--treatment period; thymol was added as a preservative.
On the final day of hormone treatment, blood samples were
obtained from the tail of each rat immediately before (T0)
and 5 hr after (T 5 ) administration of the hormone. Three
days later, upon completion of the urine collections, each
rat was decapitated. Immediately, a blood sample was taken,
the liver was excised and weighed, and the soleus, extensor
digitorum longus and gastrocnemius muscles from the left rear
leg were removed by careful dissection and individually
weighed.
9Determination of Urinary Constituents: Aliquots of the daily
urine collections were pooled within each group for 3-Mehis
and creatinine analysis. Concentrations of 3-Mehis were
determined individually on a Beckman 121 amino acid analyzer,
as previously described (13), after hydrolysis of the N-acetyl
derivative with 2 N HC1 in a boiling water bath for 1-2 hr,
and subsequent desalting on a cation exchange column (Dowex
AG50-X8) , followed by stepwise elution with I1C1 of the
acidic, neutral (2.0-2.5 N HCl) and basic (4.0-5.0 N HCl)
amino acids. The acid eluate containing the basic amino
acids was dried in a rotary evaporator and the sample was
reconstituted with citrate buffer before application to the
amino acid analyzer.
Urinary creatinine was determined by the method of
flare (14). Urinary glucose was monitored qualitatively
with an enzymatic test strip ("Tes-Tape," Eli Lilly and Co.,
Indianapolis, IN).
Plasma hormone Assays: Plasma corticosterone was determined
by the direct radioimmunoassay method described by Gomez-Sanchez
et al. (15). (The antibody was kindly provided by Dr. Gordon
Williams, Peter Bent Brigham Hospital, Boston, MA. 1,2,6,7-3H
corticosterone [92 Ci/mmole] was obtained from'tew England
Nuclear, Boston, MA.) Substantial blank values were obtained
with this method, due to non-specific binding to the antibody
1
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by materials which could not be entirely removed by charcoal
treatment. * A similar problem has been noted by others using
this method (G. Williams, personal communication) . Thus, it
is likely that the values obtained for the ADX rats are in
fact the true blank values.
insulin assays on pooled plasma samples were kindly
performed by radioinununoassay by Dr. John Allsop, Shriner's
Burns Institute, Boston, MA.
Statistical Procedures: Statistical evaluations were carried
out by conventional one- and two-way analysis of variance.
Least significant differences were calculated and are shown
i n Table 1.
RESULTS
Effect of corticosterone on body weight and organ weights:
Figure 1 shows changes in body weight of the groups of rats
during the experiments. The animals were given about 10 g
diet daily, which was essentially fully consumed, even by the
rats receiving the high corticosterone dosages. Since all
rats were pair-fed to the ADX control group, the intact
controls did not achieve the normal rate of weight gain for
males of the Sprague-Dawley strain receiving an 18% lactalbumin
diet ad libitum (about 6•-7 g/day [11]).
i
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During the 7-day period of hormone treatment, the intact
controls and the 11DX groups given 0.0, 0.2, 0.5 and 1 mg
corticosterorie/100 g body weight/day gained about 25 g; the
rates of weight gain did not differ among these groups (Table
1 and Fig. 1). Rats receiving 5 and 10 mg corticosterone/100
g body weight/day either maintained weight or lost 5-10 g,
with the major weight loss occurring on the first day or two
of treatment. Although a similar initial weight loss was
observed in rats of the group receiving 1 mg corticosterone,
this group resumed a normal growth pattern from the second
day of steroid treatment, as shown in figure 111 (insert), which
indicates the percentage change in weight from the first day
of hormone administration.
The weights of the livers and of the three skeletal
muscles removed at the end of the experiment are shown in
-, able  2. Livers of animals receiving 5 and 10 mg corticosterone
showed a considerable (P < 0.01) increase in both absolute
weight and weight/100 g final body weight, in agreement
with liver hypertrophy known to be induced by corticosteroid
treatment (16). The three muscles, representing predominantly
red (coleus), white ( extensor d.igitorum longus; EDL) and
mixed (gastrocriemius) fibers, showed differing responses.
Relative to final body weight, Lhe gastrocnemius weighed
significantly (n < 0.01) less in rats given the two highest
steroid levels, in comparison wit'
12
However, the soleus and EDL muscles did not differ from
those in the ADX controls when the weights of these muscles
were expressed per 100 g final body weight (Table 2).
Excretion of N T-methylhistidine and creatinine: Figure 2
shows the daily output of 3-Mehis/100 g body weight for
all groups of rats. Intact and ADX controls and rats given
0.2, 0.5 and 1 mg corticosterone/day showed similar output
patterns during the collection period. The initial output
of about 1.3 umoles/100 g body weight is similar to that
observed by us previously ( 11) for 100 g rats, and, as the
rats gained weight, the progressive reduction of about 25% in
3-Mehis output/100 g (Fig. 2) also agrees with our earlier
observations on growing rats (11). Output of 3-Mehis per
unit body weight or per unit creatinine excretion did not
differ significantly between intact rats and ADX rats receiving
up to 1 mg corticosterone. In contrast, administration of 5
mg corticosterone/100 g body weight/day rapidly increased
daily 3-Mehis output over 3 days to 2.3 umoles/100 g body
weight, followed by a reduction to about 1.3 proles, while
administration  of 10 mg steroid caused a persistent elevation
at' about 1.9 pmoles 3-Mehis/100 g body weight. Output of
3-Mehis by both of these groups declined to levels below
those of the other groups after steroid treatment was stopped
(Fig. 2) .
-	 13
In order to provide an index of muscle mass, and to
reduce variability from daily urine excretion, creatinine
output was measured. Figure 3 shows the ratio of 3-Mehis
i
output to creatinine excretion, expressed as a percentage
•	 change from the mean ratio of each group during the 3-day
period before hormone treatment. The ratio increased sharply
throughout treatment for animals receiving 10 mg, and during
the first half of treatment for those given 5 mg corticosterone;
these elevated ratios persisted until after treatment was
stopped. At the 1 mg dose level, there was a tendency for
output of 3-Mehis/mg creatinine to increase on the first 3
days of dosage, whereas groups on lower doses showed no
change in ratio as a result of treatment (Fig. 3).
Plasma Hormone Levels: Figure 4 shows corticosterone levels
in plasma drawn from the tail just before and 5 hr after
the last injection of corticosterone, and at the time of
}tilling 3 days later. A certain amount of non-specific
displacement of antibody-bound radioactivity by compounds in
the plasma other than corticosterone was demonstrated following
removal of authentic corticosterone by charcoal treatment.
The data have therefore been interpreted in relation to this
blank value. The values obtained for intact co'htrols fall
within the normal range reported by others (15,17). The
untreated A DX control group still showed small amounts of
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apparent corticosterone binding compared to charcoa-treated
blank values (Fig. 4); this also is probably non-specific,
and the values obtained for this group presumably represent
the true blank values for the assay. Rats receiving 0.2 and
0.5 mg corticosterone showed no apparent increase in plasma
levels of the steroid, whereas rats injected with 1, 5 or 10
mg corticosterone had increasingly elevated plasma levels 5
hr after treatment, which, in the case of the two higher dose
levels, persisted into the post-injection period, in comparison
with levels observed for the untreated ADX animals (Fig. 4).
Insulin content was measured on pooled plasma samples
for each group. The levels within all groups except for the
ADX controls were highest at 5 hr after corticosterone
administration (Fig. 5). Corticosterone doses above 0.5
mg raised plasma insulin to levels exceeding those of control
rats. At the 5 and 10 mg doses, insulin levels were still
elevated 24 hr after corticosterone injection, and these
groups also Showed gross glycosuria.
DISCUSSION
As judged by changes in growth rate and urinary excretion
of 3-Mehis, neither adrenalectomy nor replacement treatment
with 0.2 or 0.5 mg corticosterone/100 g body weight/day had
any effect when these groups were pair-fed to the ADX group
receiving the vehicle only. These two dose levels of corticosterone
are similar to those considered by Steele (18), on the basis
of various criteria,.to be optimal for replacement therapy of
ADX rats. Our data confirm this by showing that the plasma
corticosterone level 5 hr after administration of 0.5 mg
corticosterone was within the normal range in intact rats
(Fig. 4). In contrast, growth ceased and 3-Mehis output rose
sharply when rats received 5 or 10 mg corticosterone/100 g
body weight/day. These doses caused persistent elevations of
plasma corticosterone above the levels observed in intact
controls, indicating that corticosterone increases the
breakdown rate of myofibrillar protein only when excessive
t
	 levels are present in the plasma. A critical dose level for
catabolism is confirmed by the loss of weight of the gastrocnemius
muscle only at the two higher dose levels (Table 2). Our
data do not allow us to be precise about the minimum effective
dose required to induce the catabolic response. At the 1 mg
dose level of the steroid, non-significant minor effects on
growth rate and 3-Mehis output were observed. These findings
emphasize the need to establish the critical catabolic dose
of corticosterone, preferably under conditions of administration
reflecting the pattern of normal adrenal secretory activity.
The literature is contradictory regarding the action of
corticosteroids on muscle protein breakdown. Millward et
_ i]. (0) treated rats for two days with triamcinolone acetonide
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(0. 5 mg/100 g body weight) and used the technique of continuous
infusion of [ 14C]-tyrosine to measure protein synthesis in
individual muscles, from which they computed breakdown as the
difference between the estimated rate of synthesis and the net
change in muscle protein content. Although they found that
synthesis was inhibited, they did not observe a significant
increase in protein breakdown rate in rat _ .Jtrocnemius and
quadriceps muscles. Shoji and Pennington ( 8) reported that
in vitro release of tyrosine (taken to be an index of protein
breakdown) from the extensor digitorum longus muscle of rats
was not elevated following pretreatment with 10 mg cortisone
acetate/100 g body weight for 3 days. On the other hand,
Goldberg (6) injected [ 14 C]-leucine into rats and measured its
in vivo release from plantaris and soleus muscles following
administration of 10 mg cortisone acetate/100 g body weight/day
for 7-10 days, and observed an increased rate of muscle
protein breakdown in plantaris but not in soleus. Karl et
al. (19) administered 20 mg cortisone acetate on 3 successive
days to 120 g rats; 24 hr after the last dose, in vitro
release of alanine by the epitrochlaris muscle was enhanced,
implying a net protein loss from this muscle as a result of
steroid treatment.
These studies, performed on single muscles; are contradictory
and difficult to resolve due to the differences in the type
of steroid administered, the level and period of dosage, the
F
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age and sex of the rats, and the hormone responsiveness
of the individual muscles. Our data (Table 2) and those of
others (6, 20, 21) confirm that changes due to corticosteroid
administration differ among muscle types. Measurement of
urinary 3-Mehis excretion, as reported here, offers the
advantage of an integrated estimate of average protein
breakdown for the entire skeletal musculature at various dose
levels of steroid.
The persistence of the catabolic response to corticosterone
is also reflected in our studies. Since plasma corticosterone
levels were assayed after 7 days of injections, it is possible
that, due to adaptive enhancement of corticosterone removal,
the levels induced by the two highest doses declined, after
having been more elevated at the start of treatment. Nevertheless,
Figure 4 indicates that the elevated levels persisted 3 days
after the last injection of the hormone. Alternatively, the
target organs may have become to some degree refractory to
the hormone, .as indicated by the decline in 3-Mehis output
after 3-4 days of dosage with 5 mg/100 g body weight/day.
Goldman and Frohman (22) noted that the body protein content
of rats declined proportionately to body weight only after the
first day of glucocorticoid treatment,.and remained stable
thereafter. Data reported by other workers also indicate an
adaptive decline in such parameters as N excretion and plasma
glucose and insulin levels in response to continued hormone
therapy (18).
S
1The dose levels of corticosterone that caused increased
output of 3-Mehis in our studies also produced liver enlargement
(Table 2). The latter response to a high dose of glucocorticoid
agrees with other data in the literature (16) and is in
accord with observations that steroid treatment can enhance
the synthesis of RNA and protein by perfused liver (23). In
intact rats, .the critical dose level needed to produce this
hypertrophy appears to be similar to that for skeletal muscle
catabolism ('fable 1) . Although Loeb (24) found a reduction
in DNA content of rat liver following low doses of hydrocortisone,
we saw no evidence of changes in liver weight or'body weight
when our doses were less than the high levels we used to
produce a catabolic response.
The low levels of insulin in the untreated ADX control
rats agree with the finding by Sutter (25) of depressed
pancreatic insulin secretion and lack of responsiveness to
elevated plasma glucose levels in ADX rats.' This attests to
the completeness of adrenalectomy in our rats. With higher
corticosterone doses, the concorid tant elevation of insulin
levels (Fig. 4) is consistent with the findings of others
(18). The reason for the relatively low plasma insulin
levels in the group receiving 10 mg, compared to that receiving
5 mg, corticosterone/100 g body weight/day is tu%clear. Both
groups showed extensive glycosuria, indicative of corticosterone-
related insulin resistance and consequent diabetes. Thus, our
19
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data are in accord with the view that corticosteroids inhibit
entry of glucose into muscle, with resulting elevation in
plasma glucose levels and increased secretion of insulin
caused by hyperglycemia. In addition, it is well known that
corticosteroids increase gluconeogenesis, which would accentuate
the hyperglycemia.
Our data do not permit any conclusions regarding the
mechanism of the observed increase in the rate of muscle protein
breakdown.. Glucocorticoid treatment does not appear to activate
or release muscle lysosomal hydrolases (26) but does lead to
increased activity of several non-lysosomal proteases (4,5).
Mayer et al. (4) have reported a two-fold increase in a myofibrillar
protease following glucocorticoid treatment, consistent with
our finding of increased myofibrillar degradation,.as indicated
by 3-Mehis excretion, ,following administration of corticosterone
to rats in amounts sufficient to maintain elevated plasma
corticoid levels.
Finally, , it should be noted that the level of plasma
corticosteroids is elevated by a number of pathological
stress conditions. For example, rats with extensive burns can
maintain corticosterone levels higher (50-55 ug/dl) than those
noted by us in rats receiving 5 mg corticosterone/100 g body
t
weight/day for several days (Allsop, unpublished results) .
Similar elevations in corticosterone levels in response to
physical stress have been reported by others (27,28). Physiological
20
stress superimposed on physical stress can elevate plasma
co rticosterone levels in rats to 90 ug/dl for several days
(17). On the basis of these data, our results suggest that an
increased rate of muscle protein breakdown due to sustained
increased steroid secretion is likely to be a feature of the
	
•	 response to severe stress, such as in burns with infection.
Corticosterone dose not have a regulatory effect on myofibrillar
protein breakdown until levels well above the normal range are
present in the plasma.
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0.86 g
0.58 g
17.2 ntg
216.0 mg
59.1 my
14.5 mg
7.75 mg
Liver	 (g) <0.03.
(g/100 g body wt) <0.01
Soleus	 (mg) <0.05
(mg/100 g body wt) NS**
Gastrocnemius	 (mg) <0.01_
(mg/100 g body wt) <0.01
Extensor Digitorum Longus
(mg) <0.01
(mg/100 g body wt) <0.05
Urinary Excretion
during treatment
NT-methylhistidine
(umoles/day) <0.01
Fig.	 2	 (umoles/100 g body wt) <0.01
Fig.	 3	 (umoles/g creatinine) <0.01
Creatinine	 (mg/day) <0.01
(mg/100 g body wt) <0.01
Fig.	 4	 Plasma Corticosterone
(jig dl-)	 at	 0	 hr <0.01
5 hr <0.01
100 hr <0.01
0.37
0.26
320
0.55
0.39
190,
12.4
9.0
NS
>0.05<0.1
0.01
0.01
0.025
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TABLE 1
Summary of statistical analyses of body weight gain,
N T-methylhistidine and creatinine excretion,
liver and muscle weights and plasma corticosterone levels
in intact and adrenalectomized rats
receiving various doses of corticosterone.
Significance (P) of
Differences
with Respect to:
Hormone
Treatment	 Time
Body Weight Gain (g/day)
during treatment	 <0.01
Table or
Fi.aure
Fig. 1
LSD*
1.56 g
Table 2 Organ Weights
*Least significant difference between group means for P < 0.01.
**Not significant	 ORIGINAL PAGE I9
OF POOR (QUALITY
TABLE 2
Lives and muscle weights of intact and adrenalectomized (ADX) rats killed 3 days after
the final day of treatment with graded doses of corticosterone for 7 days.1
Treatment ^' Extensor
(mg cortico- Liver Gastrocnemius Soleus Dia_torum Longus
sterone/100 g g/100g of ADX mg/100g % of ADX mg/100g % of ADX mg/100g b of ADX
body wt/day) body wt control bodv wt control body wt control body wt control
Intact + 0 3.50	 ± 0.12 98 585 ± 20 105 37.4 ±	 1.6 91 49.6 ±	 2.6 107
ADX + 0 3.57	 ± 0.10 100 559 ± 16 100 40.9 ±	 1.5 100 46.2 ±	 1.6 100
ADX + 0.2 2.89
	
± 0.11 81 585 ± 15 105 37.4 ±	 2.3 91 53.0 ±	 2.2 115
ADX + 0.5 3.20	 ± 0.06 90 580 ± 8 104 33.4 ±	 4.0 82 55.4 ±	 2.4 120
ADX + 1.0 3.28	 t 0.19 92 553 t 6 99 38.4 ±	 2.4 94 49.8 ±	 1.5 108
ADX + 5.0 5.07	 ± 0.27 142 442 ± 25 79 38.3 T	 1.3 94 49.0 ±	 2.2 106
ADX + 10.0 5.96	 ± 0.23 167 400 = 11 72 38.8 ±	 1.2 95 45.2 ±	 0.4 98
1Values are means ± SEM for 4 or 5 rats.
O ^
C
iG^ b
O
0
FIGURE LEGENDS
Fig. 1: Daily body weight changes of rats before, during and
after corticosterone treatment. Values are means of 5 rats
in each of the following treatment groups: Intact + vehicle
(x-x) , adrenalectomized (ADX) + vehicle (0-0) , ADX + 0.2
(mg corticosterone/100 g body weight/day) (6-0), ADX + 0.5
(4-b) , ADX + 1. 0	 (A-4) , ADX + 5.0	 (0-0) , and ADX + 10.0
043). Injections were given subcutaneously for 7 days.
All rats were pair-fed to the average intake of ADX controls.
Fig. lA (inset): Daily body weight changes from commencement of
corticosterone injections,.expressed as a percentage change
from initial weight. Legend is as given for Fig. 1.
Fig. 2: Daily output of N T- methylliistidine/100 g body weight
before, during and after corticosterone treatment. Each
point is a pooled sample from 5 rats. Legend is as given for
Fig. 1.
Fig. 3: Daily N T- methylhistidine:creatinine ratios for each
treatment group from commencement of corticosterone
treatment, ,expressed as the percentage change from the
mean ratio of the preceding 3 days. Each point is a
pooled sample from 5 rats. Legend is as given for Fig. 1.
Fig. 4: Mean levels of corticosterone in plasma of rats
sampled from the tail just before the 7th injection (24 hr
after the 6th injection) ( TO ,FJ) , 5 hr after the 7th
,daily injection (T S ,M), and at time of killing, about
100 hr after the 7th injection (T100 11 T)  • Values are
means and SEM for 4 or 5 animals. Charcoal-treated
plasma ([I ) is mean and SEM of 1.2 samples with range of
11.5 to 71.0 ug/dl before charcoal treatment.
5: Levels of insulin in plasma samples of rats taken
0, 5, and 100 hr after corticosterone injection.
Each value is for a pooled sample from 4 or 5 rats.
Legend is as given for Fig. 4.
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